Journal for ImmunoTherapy of Cancer

Neoadjuvant intratumoral influenza vaccine treatment in patients with proficient mismatch repair colorectal cancer leads to increased tumor infiltration of CD8+ T cells and upregulation of PD-L1: a phase 1/2 clinical trial
Mikail Gögenur, Lukas Balsevicius, Mustafa Bulut, Nesibe Colak, Tobias Freyberg Justesen, Anne-Marie Kanstrup Fiehn, Marianne Bøgevang Jensen, Kathrine Høst-Rasmussen, Britt Cappelen, Shruti Gaggar, Asma Tajik, Jawad Ahmad Zahid, Astrid Louise Bjørn Bennedsen, Tommaso Del Buono D’Ondes, Hans Raskov, Susanne Gjørup Sækmose, Lasse Bremholm Hansen, Ali Salanti, Susanne Brix, Ismail Gögenur

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006774; DOI: 10.1136/jitc-2023-006774
OncoVEX^mGM-CSFexpands tumor antigen-specific CD8+ T-cell response in preclinical models
Juan Estrada, Jinghui Zhan, Petia Mitchell, Jonathan Werner, Pedro J Beltran, Jason DeVoss, Jing Qing, Keegan S Cooke

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006374; DOI: 10.1136/jitc-2022-006374
AR-A014418 regulates intronic polyadenylation and transcription of PD-L1 through inhibiting CDK12 and CDK13 in tumor cells
Ganggang Zhang, Bin Lan, Xin Zhang, Mengyao Lin, Yi Liu, Junsong Chen, Fang Guo

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006483; DOI: 10.1136/jitc-2022-006483
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade
Luke Frankiw, Arun Singh, Cole Peters, Begoña Comin-Anduix, Beata Berent-Maoz, Mignonette Macabali, Kiana Shammaie, Crystal Quiros, Paula Kaplan-Lefko, Ignacio Baselga Carretero, Antoni Ribas, Theodore Scott Nowicki

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006930; DOI: 10.1136/jitc-2023-006930
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
Eline van Diest, Patricia Hernández López, Angelo D Meringa, Anna Vyborova, Froso Karaiskaki, Sabine Heijhuurs, Jan Gumathi Bormin, Sanne van Dooremalen, Mara J T Nicolasen, Lucrezia C D E Gatti, Inez Johanna, Trudy Straetemans, Zsolt Sebestyén, Dennis X Beringer, Jürgen Kuball

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003850; DOI: 10.1136/jitc-2021-003850
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
Kirit Singh, Kelly M Hotchkiss, Aditya A Mohan, Jessica L Reedy, John H Sampson, Mustafa Khasraw

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003679; DOI: 10.1136/jitc-2021-003679
Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer
Joao V Alessi, Biagio Ricciuti, Stephanie L Alden, Arrien A Bertram, Jessica J Lin, Mustafa Sakhi, Mizuki Nishino, Victor R Vaz, James Lindsay, Madison M Turner, Kathleen Pfaff, Bijaya Sharma, Kristen D Felt, Scott J. Rodig, Justin F. Gainor, Mark M. Awad

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003536; DOI: 10.1136/jitc-2021-003536
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis
Yifei Ma, Nianqi Liu, Youlong Wang, Jiling Zeng, Ying-Ying Hu, Wu Hao, Huazheng Shi, Pengfei Zhu, Jun Lv, Wei Fan, Xinjia Wang

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e003712; DOI: 10.1136/jitc-2021-003712
Correction: Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies
Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e002444corr1; DOI: 10.1136/jitc-2021-002444corr1
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
Luis Enrique Munoz, Lei Huang, Ramireddy Bommireddy, Richa Sharma, Lenore Monterroza, Rohini N. Guin, Sarah G. Samaranayake, Christopher D. Pack, Sampath Ramachandiran, Shaker J.C. Reddy, Mala Shanmugam, Periasamy Selvaraj

Journal for ImmunoTherapy of Cancer Nov 2021, 9 (11) e002614; DOI: 10.1136/jitc-2021-002614

Main menu

Journal for ImmunoTherapy of Cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Journal for ImmunoTherapy of Cancer

Pages